Activity of antioxidant enzymes in liver and brain is decreased in the early stage of diabetes, and this decrease depends on the function of NMDA-receptors;Aktivnost' antiokislitel'nykh fermentov v pecheni i mozge snizhaetsia vrannie sroki diabeta, i éto snizhenie zavisit ot funktsionirovaniia NMDA-retseptorov.

Voprosy meditsinskoi khimii

Volumn 45, Issue 4, 1999, Pages 304-308

  Kosenko, E A ^a   Kaminskii, A I ^a   Kaminskii, I G ^a  

^a INSTITUTE OF THEORETICAL AND EXPERIMENTAL BIOPHYSICS   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOXAN; AMINO ACID RECEPTOR BLOCKING AGENT; ANTIOXIDANT; CATALASE; DIZOCILPINE MALEATE; GLUTATHIONE PEROXIDASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SUPEROXIDE DISMUTASE;

ANIMAL; ARTICLE; DRUG ANTAGONISM; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; FOREBRAIN; LIVER; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; WISTAR RAT;

ALLOXAN; ANIMALS; ANTIOXIDANTS; CATALASE; DIABETES MELLITUS, EXPERIMENTAL; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; GLUTATHIONE PEROXIDASE; LIVER; MALE; PROSENCEPHALON; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; SUPEROXIDE DISMUTASE;

EID: 0033165141     PISSN: 00428809     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)